Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine. Issue 1 (January 2022)

• Record Type: Journal Article
• Authors: Gobbi, Federico; Buonfrate, Dora; Silva, Ronaldo; Martini, Davide; Bisoffi, Zeno; Piubelli, Chiara; Riccetti, Silvia; Sinigaglia, Alessandro; Barzon, Luisa
• Is Part Of: Journal of infection. Volume 84:Issue 1(2022)
• Page Start: 94
• Page End: 118
• Publication Date: 2022-01
• Subjects: BNT162b2 vaccine -- Neutralizing antibody -- RBD-binding IgG antibody -- SARS-CoV-2 infection -- Antibody response -- mRNA vaccine -- Adverse events -- Delayed second vaccine dose; Infection -- Periodicals; Bacterial Infections -- Periodicals; Communicable Diseases -- Periodicals; Electronic journals; 616.905
• DOI: 10.1016/j.jinf.2021.08.008
• Languages: English
• ISSNs: 0163-4453

Abstract

Highlights: SARS-CoV-2 infection after the first BNT162b2 dose does not boost antibody response. A postponed second dose induced antibody titres similar to those in naïve vaccinees. We advise a second vaccine dose for individuals infected early after the first dose.